Form 4 for EXEL EXELIXIS, INC.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0000939767-25-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | 2025-02-24 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $36.75 | -27.0K | 511.9K | -5% | -$991.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | S | D | 26,987 | $36.75 | 511,908 | D | — | — | (F1) Includes 259,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. |